dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Bronchopulmonary Dysplasia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (93.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moya, F | 1 |
| Avila, E; Cook, L; Corbet, A; Edwards, K; Gerdes, J; Long, W; Puri, A; Rosenberg, A | 1 |
| Auten, RL; Balsan, MJ; Belcastro, MR; Brody, AS; Buckwald, S; Carrion, V; Donohue, PK; Durand, DJ; Egan, EA; Farrell, EE; Graeber, JE; Horgan, MJ; Hudak, ML; Jansen, RD; Jung, AL; Laskay, KM; Maniscalco, WW; Martin, DJ; Matteson, EJ; Miller, RR; Montgomery, P; Riddlesberger, MM; Rosenberg, AA; Torres, BA | 1 |
| Malathi, I; Ng, KC | 1 |
| Asselin, JM; Auten, RL; Belcastro, MR; Brody, AS; Cummings, NJ; Donohue, PK; Egan, EA; Hamm, CR; Hudak, ML; Jansen, RD; Jung, AL; Kimberlin, LV; Martin, DJ; Matteson, EJ; Montgomery, P; Riddlesberger, MM; Rosenberg, AA | 1 |
| Husain, AN; Siddiqui, NH; Stocker, JT | 1 |
| Dobner, M; Helbich, TH; Herold, CJ; Popow, C; Wunderbaldinger, P; Zekert, M | 1 |
| Anday, E; Easa, D; Gong, A; LeBlanc, M; Long, W; Pauly, T; Pramanik, A; Sell, M; Stevenson, D; Walther, F | 1 |
| Edwards, DK; Levine, D; Merritt, TA | 1 |
| Bard, H; Chernick, V; Corbet, A; Cotton, R; Courtney, S; Long, W; McGuiness, G; Smyth, J; Walter, D; Watts, J | 1 |
| Corbet, AJ; Garcia-Prats, JA; Lombardy, LR; Long, WA; Murphy, DJ; Wold, DE | 1 |
| Bucciarelli, R; Corbet, A; Goldman, S; Long, W; Mammel, M; Wold, D | 1 |
| Guthrie, R; Long, W; Schumacher, R; Sundell, H; Thompson, T; Volberg, F | 1 |
| Etches, PC; Finer, NN; Peliowski, A; Tierney, AJ | 1 |
| Bose, C; Bose, G; Corbet, A; Donlon, D; Garcia-Prats, J; Lombardy, L; Long, W; Wold, D | 1 |
1 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.
Topics: Animals; Biological Products; Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Drug Combinations; Evidence-Based Medicine; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Newborn; Intensive Care, Neonatal; Phosphatidylglycerols; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Proteins; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome | 2009 |
9 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Enterocolitis, Pseudomembranous; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1995 |
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Topics: Bronchopulmonary Dysplasia; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Incidence; Infant, Newborn; Length of Stay; Linear Models; Phosphorylcholine; Pneumothorax; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Rate; Time Factors; Treatment Outcome | 1996 |
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Topics: Age Factors; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Data Interpretation, Statistical; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Linear Models; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome | 1997 |
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Analysis | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ventilator Weaning | 1991 |
Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Follow-Up Studies; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate | 1991 |
Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Outcome and Process Assessment, Health Care; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate | 1990 |
5 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemodynamics; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Ventilation; Remission Induction; Respiration, Artificial; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ventilation-Perfusion Ratio | 1995 |
Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.
Topics: Biological Products; Body Weight; Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Organ Size; Phosphorylcholine; Polyethylene Glycols; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pulmonary Alveoli; Pulmonary Fibrosis; Pulmonary Surfactants; Retrospective Studies | 1998 |
New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
Topics: Bronchopulmonary Dysplasia; Case-Control Studies; Drug Combinations; Fatty Alcohols; Female; High-Frequency Ventilation; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Respiration, Artificial; Survival Rate; Treatment Outcome | 1998 |
Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Radiography, Thoracic; Respiratory Distress Syndrome, Newborn | 1991 |
Effect of institutional differences on study of surfactant in two centers.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Hospitals; Humans; Infant, Low Birth Weight; Infant, Newborn; Multicenter Studies as Topic; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; United States | 1991 |